{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:25:36Z","timestamp":1787430336751,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["2023-4-286"],"award-info":[{"award-number":["2023-4-286"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajg.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:51:55Z","timestamp":1782503515000},"page":"280-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and prognostic value of heme metabolism-related genes in early-stage hepatocellular carcinoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Wenxian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.04.001_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajg.2026.04.001_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-26019-8","article-title":"Deep learning for automatic segmentation of hepatocellular carcinoma in contrast enhanced CT scans","volume":"15","author":"Manghi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajg.2026.04.001_b0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/1874467215666220103111009","article-title":"Potential Therapeutic strategies to Combat HCC","volume":"15","author":"Altaf","year":"2022","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ajg.2026.04.001_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/1566523220666200628014530","article-title":"Systemic Therapy for Hepatocellular Carcinoma: advances and hopes","volume":"20","author":"Zhang","year":"2020","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.ajg.2026.04.001_b0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajg.2026.04.001_b0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000539349","article-title":"Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment","volume":"33","author":"Feng","year":"2024","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.ajg.2026.04.001_b0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2026.04.001_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/1874467212666191113130312","article-title":"FAT10: Function and Relationship with Cancer","volume":"13","author":"Xiang","year":"2020","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ajg.2026.04.001_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1874467215666221010092825","article-title":"Prevalence of Hepatocellular Carcinoma in men and the Contribution of Androgen and its Receptor in Pathogenesis and Therapy","volume":"16","author":"Abdel-Hamid","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ajg.2026.04.001_b0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41556-020-0511-2","article-title":"FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome","volume":"22","author":"Li","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajg.2026.04.001_b0055","article-title":"Integrating Bulk and Single-Cell Transcriptomics with Machine Learning reveals a Heme Metabolism-based Panel for Lung Adenocarcinoma Chemotherapy Resistance","volume":"26","author":"Zhao","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajg.2026.04.001_b0060","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-20-3913","article-title":"Targeting Oxidative Phosphorylation to increase the Efficacy of Radio- and Immune-Combination Therapy","volume":"27","author":"Boreel","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajg.2026.04.001_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0070","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fonc.2019.01540","article-title":"The Multifaceted Role of Heme in Cancer","volume":"9","author":"Fiorito","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajg.2026.04.001_b0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00018-025-05693-x","article-title":"KDM4C works in concert with GATA1 to regulate heme metabolism in head and neck squamous cell carcinoma","volume":"82","author":"Wu","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajg.2026.04.001_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1436897","article-title":"Heme (dys)homeostasis and liver disease","volume":"15","author":"Duarte","year":"2024","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajg.2026.04.001_b0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874467208666150817112345","article-title":"Review: Precision Cut Liver Slices for the Evaluation of Fatty Liver and Fibrosis","volume":"10","author":"Thiele","year":"2017","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ajg.2026.04.001_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131217","article-title":"Thorium(IV) triggers ferroptosis through disrupting iron homeostasis and heme metabolism in the liver following oral ingestion","volume":"452","author":"Ma","year":"2023","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.ajg.2026.04.001_b0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jnc.14997","article-title":"BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model","volume":"155","author":"Kataura","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajg.2026.04.001_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147974","article-title":"A Recap of Heme Metabolism towards Understanding Protoporphyrin IX Selectivity in Cancer Cells","volume":"23","author":"Kiening","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajg.2026.04.001_b0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajg.2026.04.001_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","article-title":"ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1","volume":"3","author":"Zhang","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/092986608784966895","article-title":"Intra-molecular electron transfer in proteins","volume":"15","author":"Brittain","year":"2008","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.ajg.2026.04.001_b0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/092986609788490113","article-title":"A unique mechanism of chaperone action: heme regulation of Hap1 activity involves separate control of repression and activation","volume":"16","author":"Lee","year":"2009","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.ajg.2026.04.001_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/09298665113209990092","article-title":"The species and heme pocket properties of sturgeon hemoglobins upon interaction with N-dodecyl trimethylammonium bromide","volume":"21","author":"Ariaeenejad","year":"2014","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.ajg.2026.04.001_b0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41420-025-02761-w","article-title":"Nelfinavir triggers ferroptosis by inducing ER stress mediated downregulation of GPX4\/GSH system, upregulation of NRF2\/HO-1 axis, and mitochondrial impairment in hepatocellular carcinoma cells","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ajg.2026.04.001_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080959","article-title":"Harnessing Porphyrin Accumulation in Liver Cancer: Combining Genomic Data and Drug Targeting","volume":"14","author":"Adapa","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajg.2026.04.001_b0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","article-title":"AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2026.04.001_b0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/joim.13463","article-title":"Risk of primary liver cancer in acute hepatic porphyria patients: a matched cohort study of 1244 individuals","volume":"291","author":"Lissing","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajg.2026.04.001_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr Genomics"},{"key":"10.1016\/j.ajg.2026.04.001_b0155","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/0115665232308821240826075513","article-title":"Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular Carcinoma","volume":"25","author":"Qi","year":"2025","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.ajg.2026.04.001_b0160","first-page":"25","article-title":"Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning","author":"Liu","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.ajg.2026.04.001_b0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12094-020-02390-y","article-title":"Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?","volume":"23","author":"Sun","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ajg.2026.04.001_b0170","doi-asserted-by":"crossref","unstructured":"Szlasa W, Wilk K, Knecht-Gurwin K, et al. Prognostic and Therapeutic Role of CD15 and CD15s in Cancer. Cancers (Basel) 2022;14.doi:10.3390\/cancers14092203.","DOI":"10.3390\/cancers14092203"},{"key":"10.1016\/j.ajg.2026.04.001_b0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/dmd.123.001431","article-title":"Cytochrome P450 Enzymes as Drug Targets in Human Disease","volume":"52","author":"Guengerich","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajg.2026.04.001_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231958","article-title":"Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: a Review","volume":"13","author":"Mokhosoev","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ajg.2026.04.001_b0185","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/0008-5472.CAN-14-1589","article-title":"CYP3A5 functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2\/Akt Signaling","volume":"75","author":"Jiang","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajg.2026.04.001_b0190","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/dmd.110.037853","article-title":"Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation","volume":"39","author":"Sugiyama","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajg.2026.04.001_b0195","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1111\/jcmm.15691","article-title":"Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma","volume":"24","author":"Leung","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajg.2026.04.001_b0200","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.510260616","article-title":"Chromosomal aberrations in hepatocellular carcinomas: relationship with pathological features","volume":"26","author":"Zimmermann","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2026.04.001_b0205","doi-asserted-by":"crossref","first-page":"13502","DOI":"10.18632\/aging.103454","article-title":"Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ajg.2026.04.001_b0210","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.2147\/JIR.S476388","article-title":"Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in which HILPDA Contributes to Tumor Progression","volume":"17","author":"Wang","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.ajg.2026.04.001_b0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24767","article-title":"Erythropoietin signaling regulates heme biosynthesis","volume":"6","author":"Chung","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ajg.2026.04.001_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217469","article-title":"LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation","volume":"612","author":"Xu","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajg.2026.04.001_b0225","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood.V104.11.1589.1589","article-title":"Red Blood Cells Facilitate reverse Cholesterol Transport","volume":"104","author":"Kuypers","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajg.2026.04.001_b0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/path.6161","article-title":"Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade","volume":"261","author":"Rayego-Mateos","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.ajg.2026.04.001_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1170775","article-title":"Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma","volume":"13","author":"Song","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajg.2026.04.001_b0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12967-025-06243-6","article-title":"Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD","volume":"23","author":"Zhao","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajg.2026.04.001_b0245","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241309402","article-title":"Circulating Immune Features Synergizing Neutrophil-to-Lymphocyte Ratio in Prediction of Poor Survival of Early-Stage Hepatocellular Carcinoma after thermal Ablation","volume":"24","author":"Fan","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ajg.2026.04.001_b0250","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41467-022-29012-1","article-title":"Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma","volume":"13","author":"Zakeri","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajg.2026.04.001_b0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2022.03.011","article-title":"Blocking CD47 promotes antitumour immunity through CD103(+) dendritic cell-NK cell axis in murine hepatocellular carcinoma model","volume":"77","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2026.04.001_b0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.13611","article-title":"NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-\u03b3\/p-STAT1\/IRF1 pathway","volume":"169","author":"Yu","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.ajg.2026.04.001_b0270","first-page":"7","article-title":"Linking erythropoietin to Treg-dependent allograft survival through myeloid cells","author":"Horwitz","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajg.2026.04.001_b0275","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.celrep.2015.08.010","article-title":"ABCB5 Identifies Immunoregulatory Dermal Cells","volume":"12","author":"Schatton","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajg.2026.04.001_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1483834","article-title":"The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions","volume":"15","author":"Ning","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajg.2026.04.001_b0285","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1136\/gutjnl-2021-326350","article-title":"PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma","volume":"71","author":"Lu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2026.04.001_b0290","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005414","article-title":"Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model","volume":"10","author":"Sov\u00e9","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0295","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/2159-8290.CD-21-1022","article-title":"IFN\u03b1 Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment","volume":"12","author":"Hu","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajg.2026.04.001_b0300","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2022-327133","article-title":"Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients","volume":"72","author":"Tan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2026.04.001_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000496277","article-title":"Combination Cancer Immunotherapy with Molecular Targeted Agents\/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0310","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1263\/jbb.106.248","article-title":"Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7","volume":"106","author":"Yamaguchi","year":"2008","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.ajg.2026.04.001_b0315","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1007\/s13277-015-4642-1","article-title":"Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajg.2026.04.001_b0320","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/ijc.26319","article-title":"PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma","volume":"130","author":"Dituri","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajg.2026.04.001_b0325","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.7150\/thno.99197","article-title":"Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ajg.2026.04.001_b0330","article-title":"Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma. Precis","volume":"6","author":"Wang","year":"2023","journal-title":"Clin Med"},{"key":"10.1016\/j.ajg.2026.04.001_b0335","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.2147\/OTT.S279997","article-title":"Role of Lipids and Apolipoproteins in predicting the Prognosis of Hepatocellular Carcinoma after Resection","volume":"13","author":"Ni","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ajg.2026.04.001_b0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55171-4","article-title":"The Cryo-EM structure of human CD163 bound to haptoglobin-hemoglobin reveals molecular mechanisms of hemoglobin scavenging","volume":"15","author":"Etzerodt","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajg.2026.04.001_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2024.05.008","article-title":"Potential applications of dual haptoglobin expression in the reclassification and treatment of hepatocellular carcinoma","volume":"272","author":"Liu","year":"2024","journal-title":"Transl Res"},{"key":"10.1016\/j.ajg.2026.04.001_b0350","doi-asserted-by":"crossref","unstructured":"Chavanisakun C, Keawvichit R, Benjakul N. M1 and M2 Macrophage Polarization Correlates with Activity and Chronicity Indices in Lupus Nephritis. Life (Basel) 2025;15.doi:10.3390\/life15010055.","DOI":"10.3390\/life15010055"},{"key":"10.1016\/j.ajg.2026.04.001_b0355","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphys.2014.00415","article-title":"Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development","volume":"5","author":"Schaer","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajg.2026.04.001_b0360","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","article-title":"Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis","volume":"31","author":"Ye","year":"2024","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.ajg.2026.04.001_b0365","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1566523222666220825110147","article-title":"SHR6390 combined with Cabozantinib Inhibits Tumor Progression in the Hepatocellular Carcinoma Mouse Model","volume":"24","author":"Liu","year":"2024","journal-title":"Curr Gene Ther"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:03:40Z","timestamp":1787429020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1687197926000432"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.04.001","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic value of heme metabolism-related genes in early-stage hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}